A worker operates a bilayer tablet press at ProTab Laboratories.
Photo courtesy of ProTab Laboratories.
More than 80% of Americans are currently consuming or would consider consuming foods with added health and wellness benefits.
BASF Corporation (Florham Park, NJ), the American base of the German-based chemical company, will present the S.E.T. (Sustainability, Eco-Efficiency, and Traceability) Initiative, in a VendorWorks session at the Supply Side West Conference.
BLIS Technologies Ltd. (Dunedin, New Zealand), developer of BLIS K12, a probiotic for upper airways infection prevention such as bacterial sore throats, tooth and gum disease and chronic bad breath, announced on October 17 that it had signed a distribution agreement with Frutarom, USA (North Bergen, NJ).
A new study in the October 15 issue of the Journal of the American Medical Association (JAMA; Chicago) shows that high-doses of vitamin B supplementation do little to reduce the speed of cognitive decline in Alzheimer patients.
The plant extract of Hypericum perforatum, or St. John’s wort, is grown on nearly every continent in the world, but has only recently been scientifically cited as a potential gatekeeper for depression. The study, reported in the Cochrane Systematic Review (United Kingdom) in October, included reviews of 29 trials with a total of 5,489 patients prescribed with symptoms of “major depression.”
Adrianne Bendich, Ph.D., of GlaxoSmithKline (GSK; UK) and Byron Johnson of Amway/Nutrilite (Ada, Michigan) were awarded “CRN (Steuben) Apple” awards by the Council for Responsible Nutrition (CRN; Washington DC.) at its annual symposium for the dietary supplement industry on October 6.
BENEO-Orafti (Morris Plains, NJ), a producer of inulin and oligofructose, will be exhibiting new findings on continuing research on consumer conscience in health and wellness at this year’s Health Ingredients Europe (HIE) show in France. Preliminary results will be announced from research conducted in the US and UK with other European findings being revealed at a later date.
Results of a new clinical study on UC-II®, InterHealth Nutraceuticals' (Santa Rosa, CA) Type II collagen product were presented at the American College of Nutrition (Clearwater, FL) on October 3.
More than 300 doctors and researchers discussed the latest research findigns concerning active hexose correlated compound (AHCC) at the 16th International AHCC Symposium, held July 26–27 in Sapporo, Japan. AHCC is an immune-enhancing supplement derived from the hybridization of several species of mushrooms cultivated in Japan. Amino Up Chemical Co. (Sapporo, Japan) manufactures the supplement, which is distributed by Maypro Industries Inc. (Purchase, NY) in the United States.
Alkemists Pharmaceuticals (Costa Mesa, CA) is on its way to becoming a carbon-neutral analytical laboratory by offsetting 100% of its CO2 emissions, the company said on July 30.
ChromaDex Corp. (Irvine, CA) raised $4.2 million through a private placement stock offering that began in March, the company said on August 8. New Castle Financial Services (New York City) acted as the private placement agent for the transaction, which yielded gross proceeds of $4.67 million.
Natural Alternatives International (NAI; San Marcos, CA) sold its As We Change catalog and Internet business for $2 million in cash, the company announced on August 5.The sale of the catalog business, operated by NAI’s wholly owned subsidiary Real Health Laboratories Inc., will enable NAI to concentrate on its private label and contract manufacturing clients.
The U.S. Pharmacopeia (Rockville, MD) opened a new, 1800-sq-meter facility in the Wtorre Technology Park in Sao Paulo, Brazil, on August 18. The facility, situated close to several of USP’s pharmaceutical clients, contains state-of-the-art office and laboratory space that the organization will use to dispense its publications and reference standards to local manufacturers.